| Not Yet Recruiting | Ruxolitinib for Immune Effector Cell Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (RISE) Immune Effector Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS) | Phase 1 | 2026-05-01 |
| Not Yet Recruiting | Total Pancreatectomy With Islet Autotransplantation (TPIAT) for High-Risk Patients With Pancreatic Tumors Periampullary Neoplasms, Pancreatic Cancer | N/A | 2026-05-01 |
| Recruiting | DK222 Study at Hopkins Non-Small Cell Lung Cancer, Urothelial Cancer | Phase 1 | 2026-05-01 |
| Not Yet Recruiting | Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+ HPV Infection | Phase 2 | 2026-05-01 |
| Not Yet Recruiting | A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipili Liver Cancer (Fibrolamellar Hepatocellular Cancer (FLC)) | Phase 1 | 2026-05-01 |
| Not Yet Recruiting | Precision Radiotherapy Enabled by Molecular MRI Brain Cancer | N/A | 2026-04-01 |
| Not Yet Recruiting | Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Colorectal Cancer | Phase 2 | 2026-04-01 |
| Not Yet Recruiting | Music Therapy in Newly Diagnosed Glioblastoma After Chemoradiation Therapy (MELODY-GBM) Feasibility Studies | N/A | 2026-04-01 |
| Recruiting | Momelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloprolife Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes, Myeloproliferative Overlap Neoplasms | EARLY_Phase 1 | 2026-03-19 |
| Recruiting | Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response Metastatic Castration-resistant Prostate Cancer | Phase 2 | 2026-03-09 |
| Recruiting | Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatme Head and Neck Cancer, Squamous Cell Carcinoma, Oral Cavity Cancer | Phase 2 | 2026-03-04 |
| Recruiting | Physician- and Patient-based Barriers to NGS Testing Metastatic Prostate Cancer | N/A | 2026-01-06 |
| Withdrawn | Biopsy Collection for Men Undergoing Brachytherapy for Prostate Cancer Prostate Cancer | — | 2026-01-01 |
| Recruiting | Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients Prostate Cancer, Kidney Cancer | N/A | 2025-12-01 |
| Recruiting | Pediatric Radiation Therapy Registry Sarcoma, Pediatric Brain Tumors | — | 2025-10-31 |
| Recruiting | Exercise in Prostate Cancer Prostate Cancer Metastatic, Prostate Cancer | N/A | 2025-10-16 |
| Withdrawn | PSMA Therapy and Immunotherapy in Kidney Cancer Metastatic Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma | Phase 1 / Phase 2 | 2025-10-01 |
| Recruiting | A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients Cervical Cancer | Phase 1 | 2025-09-22 |
| Recruiting | NC410 and FOLFIRINOX in Combination With Nivolumab With or Without Ipilimumab in Patients With Untreated Metas Pancreatic Cancer | Phase 2 | 2025-09-04 |
| Recruiting | The COSMYC Trial (COmbined Suppression of MYC) Metastatic Castration-resistant Prostate Cancer | Phase 2 | 2025-08-19 |
| Recruiting | KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal C Colorectal Cancer, Pancreatic Cancer | Phase 1 | 2025-06-24 |
| Recruiting | 7-Days Water-Only Fasting Trial in Prostate Cancer Metastatic Prostate Cancer | N/A | 2025-06-03 |
| Recruiting | Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectabl Pancreatic Cancer | Phase 1 / Phase 2 | 2025-05-27 |
| Recruiting | Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary T Biliary Tract Cancers | Phase 1 | 2025-05-27 |
| Recruiting | Proton SBRT for Spinal Metastasis Spinal Metastasis | N/A | 2025-04-22 |
| Recruiting | A Trial to Evaluate CSF ctDNA and Safety of Plixorafenib Alone or With Retifanlimab in Patients With BRAF-alte BRAF V600E Mutation | EARLY_Phase 1 | 2025-04-07 |
| Recruiting | Standard-of-Care Reduced-Intensity Conditioning (RIC) With 200 Versus 400 cGy of Total Body Irradiation (TBI) Acute Leukemia, Acute Lymphoblastic Lymphoma | N/A | 2025-03-27 |
| Recruiting | Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma Metastatic Sarcoma, Radiation Therapy Patient, Ewing Sarcoma | N/A | 2025-03-25 |
| Recruiting | Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma Renal Cell Carcinoma | Phase 2 | 2025-02-25 |
| Recruiting | Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients Prostate Cancer (Adenocarcinoma), Metastatic Prostate Cancer | Phase 2 | 2025-02-13 |
| Terminated | 177Lu-PSMA (177Lu-PNT2002) in PSMA-Positive Adenoid Cystic Carcinoma Adenoid Cystic Carcinoma | Phase 2 | 2025-02-10 |
| Recruiting | Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer Ovary Cancer, Fallopian Tube Cancer, Primary Peritoneal Cavity Cancer | Phase 2 | 2025-02-06 |
| Recruiting | SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization Prostate Cancer, Advanced Cancer | — | 2025-02-03 |
| Recruiting | Renal Retention in High Grade Upper Tract Urothelial Cancer High Grade Urothelial Carcinoma, Bladder Cancer, Urothelial Carcinoma Bladder | Phase 2 | 2024-11-25 |
| Recruiting | Study in Patients With Breast Cancer Leptomeningeal Metastasis Leptomeningeal Metastasis of Breast Cancer | — | 2024-11-25 |
| Withdrawn | Brachytherapy Innovations in Gynecologic Cancer Gynecologic Cancer | — | 2024-10-01 |
| Recruiting | Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Hematologic Malignancy, Bone Marrow Transplant Rejection, Acute Myeloid Leukemia (AML) | EARLY_Phase 1 | 2024-09-19 |
| Recruiting | Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming Breast Cancer, Early-stage Breast Cancer | N/A | 2024-08-08 |
| Recruiting | Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers Billiary Track Cancer | Phase 2 | 2024-07-08 |
| Recruiting | Behavioral Weight Loss for Cancer Survivors in Maryland: A Trial With Adaptive Interventions Weight Loss | N/A | 2024-06-17 |
| Recruiting | Exploration of Personalized Biomarkers During Neoadjuvant Radiation Therapy for Spinal and Sacral Chordoma Chordoma of Spine, Chordoma of Skull Base, Chordoma of Sacrum | — | 2024-06-14 |
| Recruiting | Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorect Colorectal Cancer | Phase 2 | 2024-06-13 |
| Terminated | Surgical Resection of Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma Pancreatic Ductal Adenocarcinoma, Oligometastatic Disease | N/A | 2024-05-21 |
| Recruiting | Peptide Vaccine To Prevent Acquired Resistance In Patients With Advanced ALK+ NSCLC NSCLC Stage IV, ALK Fusion Protein Expression | Phase 1 / Phase 2 | 2024-05-13 |
| Recruiting | PET Dynamics to Response-Adapted Neoadjuvant Therapy in TNBC Triple Negative Breast Cancer | Phase 2 | 2024-05-01 |
| Recruiting | Pre-operative Hypofractionated Proton Therapy Soft Tissue Sarcoma | N/A | 2024-04-18 |
| Recruiting | Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer Prostate Cancer | Phase 2 | 2024-02-16 |
| Recruiting | DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Ca Fibrolamellar Hepatocellular Carcinoma | Phase 1 / Phase 2 | 2024-02-12 |
| Withdrawn | A Neoadjuvant Study of Abiraterone Acetate, Leuprolide Acetate, and Belzutifan in Men With Regional Prostate C Prostate Cancer | Phase 2 | 2024-01-01 |
| Recruiting | Neoadjuvant Pembrolizumab and IO102-103 for Squamous Cell Carcinoma of the Head and Neck (SCCHN). Head and Neck Squamous Cell Carcinoma | Phase 2 | 2023-12-14 |
| Withdrawn | Role of Pharyngeal High Resolution Manometry and Impedance in Swallow Function of Head and Neck Cancer Patient Head and Neck Cancer, Dysphagia | N/A | 2023-12-01 |
| Active Not Recruiting | Tagraxofusp-erzs, an IL-3 Diphtheria Fusion Protein, in Combination With Gemtuzumab Ozogamicin in Patients Wit Acute Myeloid Leukemia | Phase 1 | 2023-11-20 |
| Enrolling By Invitation | Clinical Trial Assessing the Safety and Immunologic Correlates of Heterologous Prime-Boost With pNGVL4a-Sig/E7 HPV 16 Infection, HPV-Related Carcinoma, Recurrence | Phase 1 | 2023-10-18 |
| Active Not Recruiting | Safety and Efficacy of Allogeneic HPV-specific T Cells in Adults With Recurrent or Metastatic HPV16+ Cancers HPV 16+ Recurrent or Metastatic Cancer | Phase 1 / Phase 2 | 2023-10-18 |
| Recruiting | Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prosta Prostate Cancer | Phase 2 | 2023-10-04 |
| Recruiting | Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT Prostate Cancer | EARLY_Phase 1 | 2023-08-03 |
| Active Not Recruiting | Itacitinib With High-dose Posttransplantation Cyclophosphamide in Older Patients Leukemia, Acute, Myelodysplastic Syndromes, Myelomonocytic Leukemia, Chronic | Phase 1 | 2023-07-06 |
| Terminated | Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer Prostate Cancer, Castration-resistant Prostate Cancer | Phase 2 | 2023-06-30 |
| Recruiting | Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients Brain Tumor, Head and Neck Cancer | N/A | 2023-05-17 |
| Withdrawn | Neoantigen-Targeted Vaccine Combined With Anti-PD-1 Antibody for Patients With Stage IV MMR-p Colon and Pancre Pancreatic Cancer Metastatic, Colorectal Cancer Metastatic | Phase 1 | 2023-05-03 |
| Withdrawn | Neoadjuvant KRAS G12C Directed Therapy With Adagrasib (MRTX849) With or Without Nivolumab Resectable Non-Small Cell Lung Cancer | Phase 2 | 2023-03-21 |
| Withdrawn | 6 Months Adjuvant Temozolomide (TMZ) vs No Adjuvant TMZ in Newly Diagnosed MGMT Methylated Glioblastoma (GBM) MGMT-Methylated Glioblastoma | — | 2023-03-01 |
| Recruiting | Liquid Biopsy-informed Precision Oncology Study to Evaluate Utility of Plasma Genomic Profiling for Therapy Se Solid Tumor | — | 2023-01-27 |
| Withdrawn | Neoadjuvant Short-course Hypofractionated PBT for Non-metastatic RPS Retroperitoneal Sarcoma | Phase 2 | 2022-12-01 |
| Terminated | RIC alloBMT With Post-transplant Cyclophosphamide for Refractory Systemic Sclerosis Systemic Sclerosis | Phase 1 | 2022-11-18 |
| Recruiting | KRAS-Targeted Vaccine With Chemoimmunotherapy, Nivolumab and Ipilimumab for Patients With NSCLC Non-Small Cell Lung Cancer | Phase 1 | 2022-11-01 |
| Completed | Post-transplant Flotetuzumab for AML Leukemia, Myeloid, Acute | Phase 1 | 2022-10-20 |
| Terminated | SMART-ER: Symptom Monitoring With Patient-reported Outcomes Breast Cancer | N/A | 2022-10-03 |
| Recruiting | Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Gli Glioblastoma Multiforme | Phase 1 | 2022-08-31 |
| Active Not Recruiting | Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer Pancreatic Cancer | Phase 2 | 2022-08-22 |
| Recruiting | Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer Small Cell Neuroendocrine Carcinoma of Bladder, Bladder Cancer, Urothelial Carcinoma Bladder | Phase 2 | 2022-06-27 |
| Terminated | Phase II Trial of Venetoclax and Rituximab as Initial Therapy in Older Patients With Mantle Cell Lymphoma Mantle Cell Lymphoma | Phase 2 | 2022-06-21 |
| Recruiting | Cardiometabolic Screening Program Breast Cancer, Early-stage Breast Cancer | N/A | 2022-06-03 |
| Recruiting | Intraoperative Radiation Therapy After Stereotactic Body Radiation Therapy and Chemotherapy in Treatment of Pa Pancreatic Cancer | Phase 1 | 2022-05-06 |
| Recruiting | Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Prostate Adenocarcinoma, Metastatic Prostate Adenocarcinoma, Castration-resistant | Phase 2 | 2022-04-28 |
| Recruiting | Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer High Risk Cancer, Pancreatic Cancer | Phase 1 | 2022-04-11 |
| Active Not Recruiting | Proton Pencil Beam Scanning GRID for Treatment of Bulky Tumors Sarcoma, Melanoma | N/A | 2022-04-06 |
| Completed | Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastat Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer | Phase 2 | 2022-03-07 |
| Terminated | Combined Aerobic and Resistance Exercise Training in Metastatic Renal Cell Carcinoma Renal Cell Carcinoma Metastatic | N/A | 2022-02-17 |
| Recruiting | Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell Renal Cell Carcinoma (Kidney Cancer) | Phase 1 | 2022-01-26 |
| Recruiting | Trial of Cemiplimab, or Cemip-Chemo Followed by Biomarker-guided Treatment for Pts w/HPV H&N Ca HPV-Related Squamous Cell Carcinoma | Phase 2 | 2021-12-13 |
| Recruiting | Multi-agent Low Dose Chemotherapy GAX-CI Followed by Olaparib and Pembro in Metastatic Pancreatic Ductal Cance Metastatic Pancreatic Cancer | Phase 2 | 2021-09-29 |
| Completed | Durvalumab and SNDX-6532 Following Chemo or Radio-Embolization for Patients With Intrahepatic Cholangiocarcino Unresectable Intrahepatic Cholangiocarcinoma | Phase 2 | 2021-08-24 |
| Completed | HPV in Sinonasal Ca: Retrospective Analysis Association of Human Papilloma Virus (HPV) Serology and Behavioral Sinonasal Carcinoma, HPV-Related Squamous Cell Carcinoma | — | 2021-08-03 |
| Terminated | Incidence of Intracranial Hemorrhage in Glioma Patients With Venous Thromboembolism Converted From LMWH to Api Glioma, Malignant | — | 2021-08-01 |
| Withdrawn | TA-CIN Vaccine With Anti-PD-1 Therapy in Recurrent HPV16-associated Cancers Recurrent Human Papillomavirus Type 16 Associated Cancer | Phase 1 | 2021-08-01 |
| Completed | Neoadjuvant Nivolumab Plus Ipilimumab for Newly Diagnosed Malignant Peripheral Nerve Sheath Tumor Nerve Sheath Tumors | Phase 1 | 2021-06-08 |
| Terminated | Breath-Hold Technique for Pancreatic Stereotactic Body Radiation Therapy (SBRT) Patients Pancreas Cancer | N/A | 2021-06-03 |
| Active Not Recruiting | Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially R Hepatocellular Carcinoma | Phase 1 | 2021-05-28 |
| Active Not Recruiting | Neoadjuvant Targeting of Myeloid Cell Populations in Combination With Nivolumab in Head & Neck Ca Head and Neck Squamous Cell Carcinoma | Phase 2 | 2021-04-24 |
| Completed | Thoracic Epidural Analgesia vs Surgical Site Infiltration With Liposomal Bupivacaine Following Open Gynecologi Surgery, Analgesia | Phase 3 | 2021-04-14 |
| Withdrawn | Trial to Promote Recovery From COVID-19 With Endocrine Therapy COVID-19, SARS-CoV 2 | Phase 2 | 2021-04-01 |
| Recruiting | Combination Radiotherapy and Radiopharmaceutical Therapy Treatment Planning for Thyroid Cancer Recurrent Thyroid Cancer | Phase 1 | 2021-03-17 |
| Completed | Adaptive Nutrition and Exercise Weight Loss (A-NEW) Study Breast Cancer, Overweight or Obesity | Phase 2 | 2021-02-08 |
| Terminated | Camostat With Bicalutamide for COVID-19 Covid19, SARS-CoV Infection, Coronavirus Infection | Phase 1 | 2021-02-03 |
| Terminated | [18F]FLOR (FC303) PET/CT Imaging in Patients With Prostate Cancer Metastatic Prostate Cancer | Phase 1 | 2021-02-01 |
| Terminated | PET Imaging With [18F]F-AraG in Advanced Non-small Cell Lung Cancer (NSCLC) Non-small Cell Lung Cancer (NSCLC) | Phase 1 | 2021-02-01 |
| Completed | Improving Cancer On-treatment Symptom Management Cancer, Thoracic Neoplasms, Gastrointestinal Cancer | — | 2020-11-16 |
| Withdrawn | Bariatric Arterial Embolization for Men Starting Hormones for Prostate Cancer Prostate Adenocarcinoma, Obesity, Morbid | Phase 2 | 2020-11-16 |
| Completed | Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer Metastatic Pancreatic Cancer | Phase 2 | 2020-11-16 |
| Completed | TheraSphere® For Treatment of Metastases in Liver Colorectal Cancer Metastatic, Colorectal Cancer | N/A | 2020-11-12 |
| Completed | A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Bladder Cancer, NMIBC, Non-Muscle Invasive Bladder Cancer | Phase 2 | 2020-10-02 |
| Completed | Behavioral Weight Loss Program for Cancer Survivors in Maryland Breast Cancer, Prostate Cancer, Melanoma (Skin) | N/A | 2020-09-22 |
| Active Not Recruiting | Patient Response to Immunotherapy Using Spliceosome Mutational Markers (PRISMM) Metastatic Solid Tumor, SF3B1 Gene Mutation, Spliceosome Mutation | — | 2020-09-17 |
| Recruiting | HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia Human Papillomavirus Type 16, Cervical Intraepithelial Neoplasia Grade II, Cervical Intraepithelial Neoplasia, Grade III | Phase 1 | 2020-09-14 |
| Recruiting | Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression Castration Resistant Metastatic Prostate Cancer | Phase 2 | 2020-08-19 |
| Active Not Recruiting | Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma Advanced Gastric Adenocarcinoma | Phase 2 | 2020-07-31 |
| Active Not Recruiting | Intravesical Gemcitabine and Docetaxel for BCG naïve Non-muscle Invasive Bladder Cancer Urothelial Carcinoma Bladder, Bladder Cancer | Phase 2 | 2020-07-29 |
| Active Not Recruiting | Pooled Mutant KRAS-Targeted Long Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Rese Colorectal Cancer, Pancreatic Cancer | Phase 1 | 2020-05-28 |
| Recruiting | DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Nivolumab and Ipilimumab for Patients With Fibrolame Fibrolamellar Hepatocellular Carcinoma (FLC) | Phase 1 | 2020-04-20 |
| Completed | INCMGA00012 in Patients With Previously Treated Unresectable or Metastatic Adenosquamous Pancreatic or Ampulla Pancreatic Cancer Non-resectable, Pancreatic Cancer Metastatic | Phase 2 | 2020-04-09 |
| Recruiting | Proton Radiation Therapy Registry Cancer, Therapy-Related | — | 2020-04-07 |
| Completed | EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer Progression Prostatic Neoplasm | N/A | 2020-02-20 |
| Active Not Recruiting | Trial of Anti-Tim-3 in Combination With Anti-PD-1 and SRS in Recurrent GBM Glioblastoma Multiforme | Phase 1 | 2020-02-18 |
| Completed | Observation of Perioperative Outcomes of Robotic Pancreaticoduodenectomy Pancreaticoduodenectomy | N/A | 2020-02-18 |
| Completed | BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations IDH1 Mutation, IDH2 Mutation, Recurrent Glioblastoma | Phase 1 / Phase 2 | 2020-02-16 |
| Recruiting | Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Ma Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure | Phase 2 | 2020-02-12 |
| Completed | Nivolumab in Biochemically Recurrent dMMR Prostate Cancer Prostate Cancer, Recurrent Prostate Cancer | Phase 2 | 2020-01-13 |
| Terminated | AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing Surgery Brain and Central Nervous System Tumors | EARLY_Phase 1 | 2020-01-02 |
| Completed | Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreati Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC), Pancreatic Ductal Adenocarcinoma | Phase 1 / Phase 2 | 2019-12-12 |
| Terminated | Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in P High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma | Phase 1 | 2019-12-06 |
| Withdrawn | SBRT as a Vaccination for Metastatic Melanoma Metastatic Melanoma | Phase 2 | 2019-11-26 |
| Terminated | Assessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to Prostate Cancer | Phase 1 | 2019-11-15 |
| Completed | Combined Technology Enhanced Home Exercise Program and Other Non-pharmacological Intervention for Cancer Survi Cancer-related Problem/Condition, Exercise, Acupressure | N/A | 2019-10-10 |
| Completed | CTLA-4 /PD-L1 Blockade Following Transarterial Chemoembolization (DEB-TACE) in Patients With Intermediate Stag Intermediate Stage of Hepatocellular Carcinoma, Hepatocellular Carcinoma | Phase 2 | 2019-10-02 |
| Active Not Recruiting | Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma Mesothelioma | Phase 2 | 2019-10-02 |
| Withdrawn | Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer Prostate Cancer | Phase 2 / Phase 3 | 2019-10-01 |
| Terminated | Allogeneic Myeloma GM-CSF Vaccine With Lenalidomide in Multiple Myeloma Patients in Complete or Near Complete Multiple Myeloma | Phase 2 | 2019-09-23 |
| Withdrawn | Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients HPV Positive Oropharyngeal Squamous Cell Carcinoma, Oropharynx Cancer, HPV-Related Carcinoma | Phase 2 | 2019-09-17 |
| Terminated | Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancer Prostate Cancer | Phase 2 | 2019-08-28 |
| Completed | RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancers Prostate Cancer | Phase 2 | 2019-08-09 |
| Completed | Tailored Home-Based Exercise Program for Multiple Chronic Conditions Cancer, Hypertension, Diabetes | N/A | 2019-08-01 |
| Terminated | Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG High Grade Glioma, BRAF V600E, BRAF V600K | Phase 2 | 2019-07-29 |
| Completed | Preoperative Immune Checkpoint Inhibitor for Patients With Primary Untreated or Recurrent/Metastatic SCCHN Head and Neck Squamous Cell Carcinoma, Head and Neck Cancer, Head and Neck Cancer Metastatic | Phase 2 | 2019-07-08 |
| Withdrawn | Selective Transvenous Chemoembolization of Primary Pancreatic Tumors Pancreatic Adenocarcinoma | Phase 1 | 2019-07-01 |
| Withdrawn | Safety and Tolerability Study of Nivolumab and Cabiralizumab for Resectable Biliary Tract Cancer Resectable Biliary Tract Cancer | Phase 2 | 2019-06-14 |
| Terminated | A Window of Opportunity Study to Investigate Mechanisms of Actions of Novel Therapeutic Agents in Patients Wit Solid Tumor | Phase 1 | 2019-06-06 |
| Recruiting | Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer | Phase 2 | 2019-06-03 |
| Completed | Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Sup Prostate Cancer | EARLY_Phase 1 | 2019-05-10 |
| Completed | Artesunate Ointment for the Treatment of High Grade Vulvar Intraepithelial Neoplasia (HSIL VIN2/3) Vulvar Dysplasia, HPV-Related Vulvar Intraepithelial Neoplasia, Preinvasive Vulvar Disease | Phase 1 | 2019-04-17 |
| Active Not Recruiting | Dose-Escalation Study of E7727, an Oral Cytidine Deaminase Inhibitor With Oral Decitabine in Subjects With Sol Solid Tumor | Phase 1 | 2019-04-17 |
| Completed | Safety and Feasibility of TA-CIN Vaccine in HPV16 Associated Cervical Cancer HPV16 Associated Cervical Cancer | Phase 1 | 2019-04-04 |
| Completed | Test-Retest Reproducibility of 18F-DCFPyL PET/CT in the Evaluation of Patients With Metastatic Prostate Cancer Prostate Cancer | Phase 1 | 2019-03-27 |
| Terminated | Biomarker-Driven Therapy Using Immune Activators With Nivolumab in Patients With First Recurrence of Glioblast Glioblastoma, Glioblastoma Multiforme | Phase 1 | 2019-03-22 |
| Terminated | Automated Method for Breast Cancer Detection Breast Cancer Diagnosis | N/A | 2019-03-07 |
| Active Not Recruiting | REACTION (Radiation Enhanced Assessment of Combination Therapies in Immuno-ONcology) - Nivolumab or Nivolumab Gastroesophageal Cancer, Immune Checkpoint Inhibition | Phase 1 / Phase 2 | 2019-03-06 |
| Completed | Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer Microsatellite Stable (MSS) Colorectal Adenocarcinomas, Colorectal Adenocarcinoma | Phase 2 | 2019-02-12 |
| Completed | Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumor Unresectable or Metastatic Microsatellite Stable (MSS) Solid Tumor, Microsatellite Stable (MSS) Colon Cancer | Phase 1 / Phase 2 | 2019-01-17 |
| Completed | Evaluation of PSMA-based PET as an Imaging Biomarker in Prostate Cancer Advanced Prostate Cancer | EARLY_Phase 1 | 2018-12-06 |
| Recruiting | Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma | Phase 2 | 2018-11-27 |
| Active Not Recruiting | Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inh Refractory MSI - H Solid Tumors Prior of PD-(L) 1 Therapy, MSI-H Tumors | Phase 2 | 2018-11-16 |
| Active Not Recruiting | Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer Breast Cancer | Phase 2 | 2018-11-13 |
| Terminated | Study of the Effect NT-I7 on CD4 Counts in Patients With High Grade Gliomas Lymphopenia, Malignant Glioma | Phase 1 | 2018-10-30 |
| Terminated | Muscadine Plus (MPX) In Men With Prostate Cancer Adenocarcinoma of the Prostate | Phase 3 | 2018-10-30 |
| Completed | Pathologic and Immunologic Response After Ablative Radiation in Lung Cancer Non-small Cell Lung Cancer Stage I | N/A | 2018-10-16 |
| Withdrawn | A Pilot Trial of Scrambler Therapy for Pain Associated With Pancreas Cancer Cancer Pancreas, Pain Syndrome, Cancer Related Pain | — | 2018-10-01 |
| Completed | Resiliency in Older Adults Undergoing Bone Marrow Transplant Leukemia, Lymphoma, Blood Cancer | — | 2018-09-28 |
| Completed | Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adeno Pancreatic Cancer | EARLY_Phase 1 | 2018-09-27 |
| Completed | Trial of Rucaparib in Patients With Metastatic Hormone-Sensitive Prostate Cancer Harboring Germline DNA Repair Prostate Cancer Metastatic | Phase 2 | 2018-09-10 |
| Completed | COMbination of Bipolar Androgen Therapy and Nivolumab Castration-resistant Prostate Cancer, Metastatic Prostate Cancer, Prostate Cancer | Phase 2 | 2018-09-05 |
| Terminated | Skeletal Metastasis Registry Metastatic Bone Tumor | — | 2018-08-16 |
| Terminated | Idelalisib Post Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in B Cell Derived Malignancies B Cells-Tumors, B Cell Chronic Lymphocytic Leukemia, Follicular Lymphoma | Phase 1 | 2018-07-31 |
| Active Not Recruiting | Determinants of Resistance to Endocrine Therapy and a Cyclin-dependent Kinases 4 and 6 (CDK4/6) Inhibitor for Breast Cancer | Phase 2 | 2018-07-20 |
| Completed | A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cance Adenocarcinoma, Pancreatic Neoplasms, Neoplasm, Glandular | Phase 1 / Phase 2 | 2018-06-21 |
| Completed | Cancer, Obesity/Overweight and Insomnia Study Breast Cancer, Overweight and Obesity, Insomnia | N/A | 2018-06-12 |
| Completed | Radiopaque Hydrogel in Patients Undergoing Radiotherapy for Pancreatic Cancer Pancreatic Adenocarcinoma | N/A | 2018-06-06 |
| Withdrawn | Pilot Study to Define the Immune Response Following Cryoablation of Invasive Breast Cancer Invasive Ductal Carcinoma, Breast | N/A | 2018-05-22 |
| Terminated | A Biospecimen Collection Study in BRAF-V600E Mutated Recurrent Gliomas Glioma, BRAF V600E, Pleomorphic Xantho-Astrocytoma | — | 2018-05-19 |
| Completed | Feasibility and Efficacy of Neoadjuvant Cabozantinib Plus Nivolumab (CaboNivo) Followed by Definitive Resectio Locally Advanced Hepatocellular Carcinoma | Phase 1 | 2018-05-14 |
| Terminated | Radiosurgical Hypophysectomy for Bone Metasteses Pain Bone Metastases | N/A | 2018-05-08 |
| Completed | Terameprocol in Treating Patients With Recurrent High Grade Glioma High Grade Glioma (III or IV) | Phase 1 | 2018-05-03 |
| Recruiting | Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma, Solid Tumor, Adult, Solid Tumor, Childhood | Phase 1 / Phase 2 | 2018-05-01 |
| Completed | Clinical Trial of Combined Fostamatinib and Paclitaxel in Ovarian Cancer Ovarian Cancer | Phase 1 | 2018-04-03 |
| Active Not Recruiting | Study of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancer Prostate Cancer | Phase 2 | 2018-03-29 |
| Terminated | Nivolumab With Ipilimumab in Subjects With Neuroendocrine Tumors Neuroendocrine Tumors, Carcinoid Tumor | Phase 2 | 2018-03-09 |
| Completed | GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer | Phase 2 | 2018-02-02 |
| Completed | Epacadostat, Pembrolizumab, and CRS-207, With or Without CY/GVAX Pancreas in Patients With Metastatic Pancreas Metastatic Pancreatic Adenocarcinoma | Phase 2 | 2018-01-31 |
| Active Not Recruiting | Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins Metastatic Breast Cancer | N/A | 2018-01-26 |
| Completed | Study of MK-3475 (Pembrolizumab) in Patients With Microsatellite Unstable (MSI) Tumors (Cohort D) High Tumor Mutation Burden, High TMB (Tumor Mutation Burden), MSS (Microsatellite Stable) | Phase 2 | 2018-01-25 |
| Completed | Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With P Pancreatic Cancer | Phase 2 | 2017-12-14 |
| Completed | Transcranial Direct Current Stimulation (tDCS) to Improve Fatigue and Cognitive Function Breast Cancer, Fatigue | N/A | 2017-12-12 |
| Terminated | Neoadjuvant Immunoradiation for Resectable Non-Small Cell Lung Cancer Non-Small Cell Lung Cancer | Phase 2 | 2017-12-12 |
| Completed | Non-Invasive Neurosensory Testing For Chemotherapy-Induced Peripheral Neuropathy Cancer, Malignancy, Malignant Neoplasm | — | 2017-11-29 |
| Completed | A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable Metastatic Cholangiocarcinoma, Cholangiocarcinoma, Pancreatic Cancer | Phase 2 | 2017-11-06 |
| Completed | 5 Fraction Stereotactic Radiosurgery With Temozolomide for Glioblastoma Multiforme Glioblastoma Multiforme | EARLY_Phase 1 | 2017-10-18 |
| Terminated | MEDI-551 as Maintenance Therapy After Allogeneic Stem Cell Transplant in Multiple Myeloma Multiple Myeloma | Phase 2 | 2017-09-27 |
| Completed | Assessing the Acceptability of the Use of a Mobile Health App Among Young Adult Female Survivors of Childhood Childhood Cancer Survivor | N/A | 2017-09-26 |
| Completed | HIF-2 Alpha Inhibitor PT2385 in Treating Patients With Recurrent Glioblastoma Recurrent Glioblastoma | Phase 2 | 2017-09-14 |
| Active Not Recruiting | A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma, Pre B-Cell Acute Lymphoblastic Leukaemia | Phase 1 / Phase 2 | 2017-09-05 |
| Terminated | Study of Stereotactic Radiotherapy for Breast Cancer Breast Cancer | Phase 2 | 2017-08-01 |
| Completed | Involving Family to Improve Communication in Breast Cancer Care Active Breast Cancer Treatment | N/A | 2017-07-20 |
| Recruiting | Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases Brain Metastases | N/A | 2017-07-19 |
| Active Not Recruiting | Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancer Gastric Cancer, Esophageal Cancer, GastroEsophageal Cancer | Phase 1 | 2017-07-11 |
| Completed | Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer Metastatic Colorectal Cancer | Phase 2 | 2017-05-26 |
| Active Not Recruiting | Neoadjuvant Nivolumab With and Without Urelumab in Cisplatin-Ineligible or Chemotherapy-refusing Patients With Urothelial Carcinoma, Bladder Cancer | Phase 2 | 2017-05-16 |
| Terminated | Pembrolizumab in Patients With Leptomeningeal Disease Patients With Leptomeningeal Disease | Phase 2 | 2017-04-12 |
| Terminated | Study Assessing the Feasibility of a Surgery and Chemotherapy-Only in Children With Wnt Positive Medulloblasto Medulloblastoma | EARLY_Phase 1 | 2017-04-04 |
| Terminated | Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, Clarithromycin Prostate Cancer | Phase 1 | 2017-03-21 |
| Completed | Post-Operative Outcomes of Low Thermal Dissection vs. Traditional Electrosurgery Breast Cancer, Mastectomy, Perfusion; Complications | N/A | 2017-03-17 |
| Active Not Recruiting | Nivolumab With or Without Stereotactic Radiosurgery in Treating Patients With Recurrent, Advanced, or Metastat Chordoma | Phase 1 | 2017-03-10 |
| Active Not Recruiting | Olaparib in Men With High-Risk Biochemically-Recurrent Prostate Cancer Following Radical Prostatectomy, With I Prostate | Phase 2 | 2017-03-01 |
| Completed | Trial of Mistletoe Extract in Patients With Advanced Solid Tumors Solid Tumor | Phase 1 | 2017-03-01 |
| Completed | A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy Prostate Cancer | Phase 2 | 2017-02-22 |
| Active Not Recruiting | Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer Prostate Cancer | Phase 2 | 2017-02-14 |
| Terminated | Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Ca Prostate Cancer | Phase 1 | 2017-02-09 |
| Terminated | Study of IRX5183 in Relapsed and Refractory Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML) | Phase 1 | 2017-01-30 |
| Withdrawn | Markers for Predicting Risk of Breast Cancer in Women of Different Races Breast Cancer | — | 2017-01-01 |
| Recruiting | Image-Guided Gynecologic Brachytherapy Cervical Cancer, Uterine Cancer, Vaginal Cancer | N/A | 2016-12-15 |
| Completed | Perspectives on Bone Marrow Donors Who Donate for Their Parent Bone Marrow Transplant | — | 2016-12-06 |
| Terminated | Phase 2 Study of Nivolumab in Solid Tumors Induced by Prior Radiation Exposure Solid Tumors Induced by Prior Radiation Exposure | Phase 2 | 2016-12-01 |
| Active Not Recruiting | Palbociclib With Fulvestrant for Metastatic Breast Cancer After Treatment With Palbociclib and an Aromatase In Metastatic Breast Cancer | Phase 2 | 2016-10-25 |
| Terminated | Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (S Lupus Erythematosus, Graft-versus-host Disease | Phase 1 / Phase 2 | 2016-09-13 |
| Completed | NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic Anemia Severe Aplastic Anemia, Aplastic Anemia, Bone Marrow Failure | Phase 2 | 2016-09-01 |
| Recruiting | Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies Head and Neck Cancer, Lung Cancer, Gastrointestinal Cancer | — | 2016-08-25 |
| Completed | Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16 Glioblastoma, Gliosarcoma, Recurrent Brain Neoplasm | Phase 1 | 2016-08-24 |
| Completed | Comparison of PSMA-based 18F-DCFPyL PET/CT to Conventional Imaging in the Evaluation of Patients With Castrati Prostate Cancer | — | 2016-08-03 |
| Completed | Study With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic Can Pancreatic Cancer | Phase 2 | 2016-07-18 |
| Completed | Study of Azacitidine in Combination With Pembrolizumab in R/R AML Patients and in Newly Diagnosed Older Patien Acute Myeloid Leukemia | Phase 2 | 2016-07-01 |
| Active Not Recruiting | Monitoring Plasma Tumor DNA in Early-Stage Breast Cancer Breast Cancer | — | 2016-07-01 |
| Terminated | Pilot Study of Mobilization and Treatment of Disseminated Tumor Cells in Men With Metastatic Prostate Cancer Prostate Cancer | Phase 1 | 2016-07-01 |
| Completed | SRS and Nivolumab in Treating Patients With Newly Diagnosed Melanoma Metastases in the Brain or Spine Metastatic Malignant Neoplasm in the Brain, Metastatic Malignant Neoplasm in the Spine, Stage IV Skin Melanoma | Phase 1 | 2016-06-23 |
| Terminated | Docetaxel With or Without Ascorbic Acid in Treating Patients With Metastatic Prostate Cancer Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer | Phase 2 | 2016-06-20 |
| Withdrawn | Head and Neck Cancer Treatment Related Dysphagia Head and Neck Cancer, Dysphagia | — | 2016-06-09 |
| Completed | Study of the Clinical Utility of PSMA Imaging in the Evaluation of Men With Prostate Cancer Prostate Cancer | — | 2016-06-08 |
| Completed | A Study of Definitive Therapy to Treat Prostate Cancer Prostate Cancer | Phase 2 | 2016-06-01 |
| Completed | Evaluation of 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer. Metastatic Prostate Cancer | Phase 1 | 2016-05-16 |
| Active Not Recruiting | Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer | Phase 2 | 2016-05-03 |
| Completed | Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors Medulloblastoma, Astrocytoma, Grade III, Glioblastoma | Phase 1 | 2016-05-01 |
| Terminated | Ultrasound Monitoring of Abdominal Soft Tissue Pancreatic Cancer, Liver Cancer | N/A | 2016-05-01 |
| Completed | Stereotactic Body Radiation for Prostate Oligometastases Prostate Cancer, Oligometastases | Phase 2 | 2016-04-28 |
| Active Not Recruiting | Platform Study of Neoadjuvant and Adjuvant Immunotherapy for Patients With Resectable Adenocarcinoma of the Pa Pancreatic Cancer | Phase 2 | 2016-03-28 |
| Completed | Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer, Recurrent Prostate Carcinoma, Stage IV Prostate Adenocarcinoma | Phase 2 | 2016-03-15 |
| Withdrawn | Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocell Fibrolamellar Hepatocellular Carcinoma, Hepatocellular Carcinoma (Fibrolamellar Variant), Hepatocellular Carcinoma | Phase 2 | 2016-03-01 |
| Completed | Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPC Prostate Cancer | Phase 2 | 2016-02-22 |
| Completed | A Study of Enhancing Response to MK-3475 in Advanced Colorectal Cancer Colorectal Cancer | Phase 1 | 2016-02-19 |
| Completed | Study of Neoadjuvant Nivolumab in Patients With Non-metastatic Stage II-IV Clear Cell Renal Cell Carcinoma Clear Cell Renal Cell Carcinoma | Phase 1 | 2016-02-01 |
| Completed | Vibrent Smartphone Mobile Application Mucositis | N/A | 2016-01-14 |
| Terminated | Study of Tremelimumab Alone or Combined With Olaparib for Patients With Persistent EOC (Epithelial Ovarian, Fa Primary Peritoneal Carcinoma | Phase 1 | 2016-01-08 |
| Completed | Pembrolizumab and Cryosurgery in Treating Patients With Newly Diagnosed, Oligo-metastatic Prostate Cancer Stage IV Prostate Cancer | N/A | 2015-12-11 |
| Completed | Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malig Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Small Lymphocytic Lymphoma | Phase 2 | 2015-12-01 |
| Completed | Simplifying Survivorship Care Planning Cancer | N/A | 2015-10-01 |
| Terminated | Dexamethasone Prior to Re-treatment With Enzalutamide in Treating Patients With Metastatic Hormone-Resistant P Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Prostate Adenocarcinoma | N/A | 2015-09-01 |
| Withdrawn | Trial of Vemurafenib and Cobimetinib in Patients With Advanced BRAFV600 Mutant Melanoma Melanoma | Phase 3 | 2015-08-01 |
| Completed | Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Myeloablative Conditioning, HLA-mismatched Bone Marrow Transplantation, Graft Survival | Phase 2 | 2015-07-02 |
| Completed | A Safety Study of Fingolimod With Radiation and Temozolomide in Newly Diagnosed High Grade Glioma Glioblastoma, Anaplastic Astrocytoma | EARLY_Phase 1 | 2015-07-01 |
| Completed | Utilizing Advance Care Planning Videos to Empower Perioperative Cancer Patients and Families Cancer | N/A | 2015-07-01 |
| Completed | Pilot Study of 18F-DCFPyL PET/CT in the Evaluation of Men With an Elevated PSA Following Radical Prostatectomy Adenocarcinoma of the Prostate | N/A | 2015-06-02 |
| Completed | Adoptive Immunotherapy With Activated Marrow Infiltrating Lymphocytes and Cyclophosphamide Graft-Versus-Host D Hematologic Malignancies, Graft-Versus-Host Disease | Phase 1 | 2015-05-28 |
| Completed | Survivorship Promotion In Reducing IGF-1 Trial Breast Cancer, Prostate Cancer, Lung Cancer | Phase 2 | 2015-05-01 |
| Completed | Evaluating the Effects of Psycho-oncological Education on Distress and Quality of Life in Solid Tumor Cancer P Quality of Life | N/A | 2015-05-01 |
| Completed | Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy Adenocarcinoma of the Prostate | Phase 2 | 2015-03-28 |
| Terminated | FBnTP Imaging of Breast Cancer Breast Cancer | Phase 1 | 2015-03-12 |
| Withdrawn | A Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Ca Prostate Cancer, Bone-only Metastatic Castration-Resistant Prostate Cancer (CRPC) | Phase 1 | 2015-03-01 |
| Completed | Scrambler Therapy in the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy Neuropathy | N/A | 2015-03-01 |
| Completed | Targeted Imaging of Glutamate Carboxypeptidase II With DCFPyL-PET Schwannomas, Malignant Tumors | Phase 1 | 2015-02-06 |
| Completed | Study of Gemcitabine/Taxotere/Xeloda (GTX) in Combination With Cisplatin and Irinotecan in Subjects With Metas Metastatic Pancreatic Adenocarcinoma | Phase 1 / Phase 2 | 2015-02-01 |
| Completed | Intravaginal Artesunate for the Treatment of HPV+ High Grade Cervical Intraepithelial Neoplasia (CIN2/3) Cervical Intraepithelial Neoplasia Grade 2/3, High-risk HPV (Any Strain) | Phase 1 | 2015-02-01 |
| Completed | Patient and Provider Initiated Survivorship Care Planning Cancer | N/A | 2015-02-01 |
| Completed | Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson Administration Blood Brain Barrier Defect | EARLY_Phase 1 | 2015-02-01 |
| Completed | Immunologic Responses in HPV-Associated Carcinoma for Patients Receiving Chemoradiation Head and Neck Cancer, HPV (Human Papillomavirus)-Associated Carcinoma, Oropharyngeal | — | 2015-01-07 |
| Completed | GVAX Pancreas Vaccine (With CY) and CRS-207 With or Without Nivolumab Previously Treated Metastatic Adenocarcinoma of the Pancreas | Phase 2 | 2015-01-02 |
| Completed | Testosterone Revival Abolishes Negative Symptoms, Fosters Objective Response and Modulates Enzalutamide Resist Castration Resistant Metastatic Prostate Cancer | Phase 2 | 2015-01-01 |
| Completed | Cancer DNA Detection in Blood and Urine Prostate Cancer | — | 2014-11-01 |
| Completed | Intraoperative Dosimetry for Prostate Brachytherapy Using Fluoroscopy and Ultrasound Prostate Cancer, Adenocarcinoma of the Prostate | N/A | 2014-10-01 |
| Active Not Recruiting | Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC Non-Small Cell Lung Cancer | Phase 2 | 2014-09-01 |
| Withdrawn | Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Eribulin Chemotherapy (ACE) in Operable HER2-negative Bre Breast Cancer | Phase 2 | 2014-09-01 |
| Withdrawn | Reiki as a Complementary Therapy: A Pilot Study Hematologic Malignancy | N/A | 2014-09-01 |
| Completed | RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study) Prostate Cancer | Phase 2 | 2014-08-25 |
| Terminated | Pilot Study Using Amide Proton Transfer Magnetic Resonance Imaging Distinguishing Glioma Gliosarcoma, Glioma | N/A | 2014-08-01 |
| Completed | Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia, Bone Marrow Failure Syndromes | Phase 2 | 2014-08-01 |
| Active Not Recruiting | Subventricular Zone (SVZ) and Temozolomide in Glioblastoma Multiforme Glioblastoma Multiforme | Phase 2 | 2014-07-08 |
| Terminated | Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Kaposi Sarcoma | EARLY_Phase 1 | 2014-07-01 |
| Completed | Chemoradiation or Brachytherapy for Rectal Cancer Rectal Cancer | Phase 2 | 2014-06-12 |
| Completed | A Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects Metastatic Pancreatic Adenocarcinoma | Phase 1 | 2014-06-10 |
| Terminated | Study of Rituximab and Brentuximab Vedotin for Relapsed Classical Hodgkin Lymphoma Lymphoma | Phase 1 | 2014-06-01 |
| Terminated | Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer | Phase 2 | 2014-05-20 |
| Completed | A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive Cancers Tobacco Use Disorder, Head and Neck Neoplasms, Thoracic Neoplasms | N/A | 2014-05-01 |
| Completed | Study of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Pro Metastatic Prostate Cancer | Phase 1 | 2014-05-01 |
| Completed | Lenalidomide, Dexamethasone and MEDI-551 in Untreated Multiple Myeloma Myeloma | EARLY_Phase 1 | 2014-05-01 |
| Completed | SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metast Metastatic Colorectal Cancer | Phase 1 | 2014-04-14 |
| Completed | Red Cell Transfusion Goals in Patients With Acute Leukemias Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia (ALL), Acute Myelogenous Leukemia (AML) | Phase 1 | 2014-04-01 |
| Withdrawn | Integrating Palliative Care and Modern Palliative Care Tools Into the Care of Patients With Pancreas Cancer Pancreas Cancer | — | 2014-04-01 |
| Completed | A Study of Vismodegib in Men With Metastatic CRPC With Accessible Metastatic Lesions for Tumor Biopsy Prostate Cancer | EARLY_Phase 1 | 2014-04-01 |
| Completed | A Pre-surgical Study of LDE225 in Men With High-risk Localized Prostate Cancer Prostate Cancer | Phase 1 | 2014-04-01 |
| Withdrawn | A Phase 2 Study of Bicalutamide Plus Finasteride in Men With MRI Detectable Prostate Nodules Undergoing Active Detectable Prostate Nodules | Phase 2 | 2014-03-01 |
| Active Not Recruiting | Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer Breast Cancer | Phase 2 | 2014-01-30 |
| Completed | Trial to Improve Outcomes in Patients With Resected Pancreatic Cancer (Azacitidine) Pancreatic Cancer | Phase 2 | 2014-01-10 |
| Completed | Stereotactic Body Radiation With Nelfinavir for Oligometastases Oligometastases | Phase 2 | 2014-01-08 |
| Completed | A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL Acute Lymphoblastic Leukemia (ALL) | EARLY_Phase 1 | 2014-01-06 |
| Terminated | Consolidation Therapy for Acute Myeloid Leukemia Guided by Leukemia Stem Cell Behavior Acute Myeloid Leukemia | Phase 2 / Phase 3 | 2013-12-01 |
| Completed | Phase II Anti-PD1 Epigenetic Therapy Study in NSCLC. Non-Small Cell Lung Cancer, Epigenetic Therapy | Phase 2 | 2013-11-06 |
| Completed | FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic Cancer Metastatic Pancreatic Adenocarcinoma | Phase 2 | 2013-11-01 |
| Completed | Stereotactic Radiation Therapy for Pediatric Sarcomas Sarcoma, Metastatic Disease, Bony Sites | N/A | 2013-11-01 |
| Completed | Phase I/II Study of SGI-110 With Irinotecan Versus Regorafenib or TAS-102 in Metastatic Colorectal Cancer Previously Treated Metastatic Colorectal Cancer | Phase 1 / Phase 2 | 2013-10-23 |
| Terminated | Allogeneic Human Bone Marrow Derived Mesenchymal Stem Cells in Localized Prostate Cancer Prostate Cancer | Phase 1 | 2013-10-01 |
| Completed | Tumor Motion Management in Radiotherapy Using 4D-MRI Cancer | — | 2013-10-01 |
| Completed | IMAGE Study: Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins Metastatic Breast Cancer | N/A | 2013-09-19 |
| Completed | Study of MK-3475 in Patients With Microsatellite Unstable (MSI) Tumors (Cohorts A, B and C) MSI Positive Colorectal Cancer, MSI Negative Colorectal Cancer, MSI Positive Non-Colorectal Cancers | Phase 2 | 2013-09-01 |
| Terminated | SRS (Stereotactic Radiosurgery) Plus Ipilimumab Newly Diagnosed Melanoma Metastases in the Brain and Spine | Phase 1 | 2013-09-01 |
| Completed | Tadalafil and Lenalidomide Maintenance With or Without Activated Marrow Infiltrating Lymphocytes (MILs) in Hig Multiple Myeloma | Phase 2 | 2013-09-01 |
| Terminated | Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma Metastatic Osteosarcoma | Phase 2 | 2013-08-19 |
| Completed | Robot-Assisted MRI-Guided Prostate Biopsy Prostate Cancer | N/A | 2013-07-25 |
| Completed | POWER-remote Weight Loss Program in Early Stage Breast Cancer Early Stage Breast Cancer | N/A | 2013-07-01 |
| Completed | Phase II Study of Azacitidine and Sargramostim as Maintenance Treatment for Poor-Risk AML or MDS Acute Myeloid Leukemia, Myelodysplastic Syndrome | Phase 2 | 2013-06-01 |
| Completed | Optimized Antiretroviral Therapy During Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 Individual HIV | EARLY_Phase 1 | 2013-06-01 |
| Completed | Radiation and Androgen Ablation for Prostate Cancer Adenocarcinoma of the Prostate | Phase 1 / Phase 2 | 2013-05-22 |
| Completed | Radiotherapy for Solid Tumor Spine Metastases Solid Tumor Spine Metastases | Phase 2 | 2013-05-20 |
| Completed | Mebendazole in Newly Diagnosed High-Grade Glioma Patients Receiving Temozolomide Newly Diagnosed High-Grade Glioma | Phase 1 | 2013-04-04 |
| Recruiting | Reduced Intensity Haploidentical BMT for High Risk Solid Tumors Refractory and/or Relapsed Metastatic Solid Tumors | Phase 2 | 2013-03-27 |
| Completed | Hippocampal Prophylactic Cranial Irradiation for Small Cell Lung Cancer Small-cell Lung Cancer, SCLC, Small Cell Lung Cancer Limited Stage | N/A | 2013-03-11 |
| Completed | Intra-arterial Chemotherapy for the Treatment of Progressive Diffuse Intrinsic Pontine Gliomas (DIPG). Diffuse Intrinsic Pontine Glioma (DIPG) | Phase 1 | 2013-03-08 |
| Completed | Evaluation of 18F-DCFBC PSMA-based PET Imaging for Detection of Metastatic Prostate Cancer Metastatic Prostate Cancer | Phase 1 / Phase 2 | 2013-03-01 |
| Terminated | A Randomized Phase II Study of SUBATM-itraconazole in Patients With Untreated Squamous NSCLC. Non-small Cell Lung Cancer Metastatic | Phase 2 | 2013-03-01 |
| Completed | Group Intervention to Increase Physical Activity in Childhood Cancer Survivors Pediatric Cancer | EARLY_Phase 1 | 2013-02-01 |
| Completed | A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localized Prostat Prostate Cancer Adenocarcinoma in Situ | Phase 1 / Phase 2 | 2013-01-18 |
| Completed | Bipolar Androgen-based Therapy for Prostate Cancer (BAT) Recurrent Prostate Cancer | Phase 2 | 2013-01-01 |
| Completed | DIG-HIF-1 Pharmacodynamic Trial in Newly Diagnosed Operable Breast Cancer Breast Cancer | Phase 2 | 2013-01-01 |
| Completed | Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma Pancreatic Cancer, Periampullary Adenocarcinoma | Phase 2 | 2013-01-01 |
| Terminated | A Phase I/II Study Afatinib/Carboplatin/Paclitaxel Induction Chemotherapy In HPV-Negative HNSCC. Squamous Cell Carcinoma of the Head and Neck | Phase 1 / Phase 2 | 2012-12-01 |
| Completed | Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Metastatic Esophageal Cancer, Gastroesophageal Cancer, Gastric Cancer | Phase 2 | 2012-12-01 |
| Active Not Recruiting | MRI for Assessing Prostate Cancer Response Prostate Cancer | N/A | 2012-11-16 |
| Completed | Pancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenoca Pancreatic Cancer | Phase 2 | 2012-10-29 |
| Completed | Evaluation of Prostate-specific Membrane Antigen (PSMA)-Based PET Imaging of Primary Prostate Cancer Prostate Cancer | Phase 1 / Phase 2 | 2012-09-11 |
| Terminated | Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Metastatic Colorectal Adenocarcinoma Metastatic Colorectal Adenocarcinoma | Phase 2 | 2012-09-10 |
| Completed | Maintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in Lymphoma CD20+, B-cell Lymphomas, Mantle Cell Lymphoma, Non-Mantle Cell Low Grade B Cell Lymphomas (SLL/CLL) | Phase 2 | 2012-09-01 |
| Completed | Low Dose Radiation Therapy for Glioblastoma Multiforme High Grade Glioma | Phase 2 | 2012-09-01 |
| Completed | A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract Head and Neck Squamous Cell Carcinoma | Phase 2 | 2012-09-01 |
| Terminated | A Phase 1 Trial of TST of PD 0332991 Followed by Cytarabine and Mitoxantrone for Adults With Relapsed and Refr Relapsed Acute Leukemia, Refractory Acute Leukemia, High-Risk Myelodysplasia | Phase 1 | 2012-09-01 |
| Terminated | Phase I Study of Orally Administered Aminolevulinic Acid for Resection of Malignant Astrocytomas Astrocytoma, Glioma | Phase 1 | 2012-09-01 |
| Completed | Prospective Evaluation of T-cell Immune Status in Patients With Newly Diagnosed High Grade Gliomas High Grade Glioma | N/A | 2012-07-13 |
| Terminated | Pre-Prostatectomy Lovastatin on Prostate Cancer Prostate Cancer | N/A | 2012-07-13 |
| Completed | Feasibility of Lymphocyte Reinfusion in Newly Diagnosed High Grade Gliomas Glioblastoma | N/A | 2012-07-01 |
| Completed | Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma Brain and Central Nervous System Tumors | Phase 1 | 2012-05-31 |
| Completed | Johns Hopkins Breast Cancer Program Hormone Therapy Longitudinal Database Breast Cancer | — | 2012-05-09 |
| Terminated | Study of Metformin Plus Paclitaxel/Carboplatin/Bevacizumab in Patients With Adenocarcinoma. Carcinoma, Non-Small-Cell Lung, Lung Adenocarcinoma | Phase 2 | 2012-05-01 |
| Completed | PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy Melanoma, Renal Cell Carcinoma (RCC), Non-small Cell Lung Cancer (NSCLC) | EARLY_Phase 1 | 2012-04-16 |
| Terminated | Safety Study of HPV DNA Vaccine to Treat Head and Neck Cancer Patients Head and Neck Cancer | Phase 1 | 2012-04-01 |
| Terminated | Administration of Tadalafil in Conjunction With Lenalidomide and Dexamethasone in Patients With Multiple Myelo Multiple Myeloma | Phase 2 | 2012-04-01 |
| Completed | A Trial of Oral 5-azacitidine in Combination With Romidepsin in Advanced Solid Tumors, With an Expansion Cohor Solid Tumors, Virally Mediated Cancers and Liposarcoma | Phase 1 | 2012-02-01 |
| Completed | Allogeneic GM-CSF Vaccine and Lenalidomide in Treating Myeloma Patients With Near Complete Remission Multiple Myeloma | Phase 2 | 2012-01-01 |
| Terminated | A Feasibility Study of a Modular Video Augmentation System for Image-Guided Skull Base Surgery Feasibility of Video Augmentation System, Value of Video Augmentation Navigation | N/A | 2012-01-01 |
| Completed | Neural Progenitor Cell Sparing Radiation Therapy Plus Temozolomide Glioblastoma Multiforme | N/A | 2011-12-27 |
| Terminated | Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarc Pancreatic Ductal Adenocarcinoma | Phase 1 / Phase 2 | 2011-12-27 |
| Completed | Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic Cancer Pancreatic Cancer | Phase 2 | 2011-11-01 |
| Completed | Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiate Solid Tumors, Thyroid Cancer, Soft-tissue Sarcoma | Phase 1 | 2011-10-01 |
| Terminated | Decision Support for Women With Breast Cancer Breast Neoplasms | N/A | 2011-09-01 |
| Completed | Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resecte Melanoma | Phase 1 | 2011-09-01 |
| Completed | Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cycloph Hodgkin's Lymphoma, Leukemia, Myelodysplastic Syndrome(MDS) | Phase 1 | 2011-08-01 |
| Completed | Effects of Two Doses of MPX Capsules on Rising Prostate-specific Antigen Levels in Men Following Initial Thera Prostate Cancer | Phase 1 / Phase 2 | 2011-07-01 |
| Completed | Endothelial Function, Arterial Stiffness and Components Acute Lymphoblastic Leukemia | — | 2011-06-01 |
| Terminated | CHFR Methylation Status Esophageal Cancer Study Esophageal Cancer | Phase 2 | 2011-06-01 |
| Terminated | Bone Marrow Transplant Trial for Patients With Refractory Severe Aplastic Anemia Severe Aplastic Anemia | Phase 2 | 2011-06-01 |
| Completed | Evaluation of a Transrectal Scintigraphic Detector(ProxiScanTM) for Detection of Primary Prostate Cancer Suspected Primary Prostate Cancer | Phase 1 | 2011-05-01 |
| Terminated | Patient-donor Vaccination in the Context of Allogeneic Bone Marrow Transplant With Post-transplant Cyclophosph Transplant-Related Cancer | Phase 2 | 2011-04-01 |
| Terminated | Intra-arterial Chemotherapy for the Treatment of Intraocular Retinoblastoma Retinoblastoma | Phase 2 | 2011-03-01 |
| Terminated | A Study of Vorinostat and Tamoxifen in Newly Diagnosed Breast Cancer Stage I Breast Cancer, Stage II Breast Cancer, Stage III Breast Cancer | Phase 2 | 2011-03-01 |
| Completed | Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms Ductal Carcinoma in Situ, Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer | Phase 2 | 2011-02-01 |
| Completed | Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer Pancreatic Cancer | Phase 1 | 2011-01-01 |
| Completed | 124I-FIAU Imaging in EBV and KSHV Associated Cancers Hodgkin Lymphoma, Non Hodgkin Lymphoma, Kaposi's Sarcoma | N/A | 2010-12-01 |
| Completed | Study of High-Dose-Rate Endorectal Brachytherapy (HDRBT) in the Treatment of Locally Advanced Low Rectal Cance Rectal Cancer | N/A | 2010-10-26 |
| Completed | Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas Metastatic Pancreatic Cancer | Phase 2 | 2010-09-17 |
| Completed | Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies Hematologic Malignancies | Phase 1 / Phase 2 | 2010-09-01 |
| Completed | Biodistribution and Pharmacokinetic Study of 18F-DCFBC Prostate Specific Membrane Antigen Based PET in Patient Prostate Cancer | Phase 1 | 2010-09-01 |
| Terminated | Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hemato Lymphoma, Leukemia, Myelodysplastic Syndrome | Phase 2 | 2010-08-01 |
| Completed | Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma M Adult Glioblastoma Multiforme | Phase 2 | 2010-07-01 |
| Completed | Study of Recurrent Prostate Cancer With Rising Prostate Specific Antigen (PSA) Prostate Cancer | N/A | 2010-05-01 |
| Active Not Recruiting | Boost GVAX Pancreas Vaccine With or Without CY in Patients With Pancreas Cancer Pancreatic Cancer | Phase 2 | 2010-04-20 |
| Completed | Treatment De-Intensification for Squamous Cell Carcinoma of the Oropharynx Squamous Cell Carcinoma of Oropharynx | Phase 2 | 2010-03-01 |
| Completed | A Pilot Study of Parenteral Testosterone and Oral Etoposide as Therapy for Men With Castration Resistant Prost Prostate Cancer | N/A | 2010-03-01 |
| Terminated | An Early Safety and Efficacy Study of Ascites Management: Standard Paracentesis or Early Intervention With Ple Malignant Ascites | N/A | 2010-02-01 |
| Completed | Trial of Activated Marrow Infiltrating Lymphocytes Alone or in Conjunction With an Allogeneic Granulocyte Macr Multiple Myeloma | Phase 2 | 2010-01-15 |
| Completed | Cytokine Expression During Radiation for Breast Cancer Breast Cancer | N/A | 2009-11-13 |
| Terminated | RAD001 in Combination With Cetuximab and Cisplatin in Recurrent and Metastatic SCCHN Head and Neck Cancer | Phase 1 / Phase 2 | 2009-10-01 |
| Completed | Using High Resolution Function Imaging To Detect Melanoma and Dysplastic Nevi Melanoma | — | 2009-09-22 |
| Completed | Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma Sarcoma | Phase 1 / Phase 2 | 2009-09-01 |
| Completed | Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3) HPV16 Positive, Cervical Intraepithelial Neoplasia (CIN 2/3) | Phase 1 | 2009-09-01 |
| Completed | ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Brain and Central Nervous System Tumors | Phase 1 | 2009-07-13 |
| Terminated | Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituxima Lymphoma, B-cell Lymphoma, Non Hodgkin Lymphoma | Phase 2 | 2009-07-01 |
| Completed | Cyclophosphamide and Vaccine Therapy With or Without Trastuzumab in Treating Patients With Metastatic Breast C Breast Cancer | Phase 2 | 2009-07-01 |
| Terminated | A Study of Dasatinib, Cetuximab and Radiation With or Without Cisplatin in HNSCC Head and Neck Cancer | Phase 1 | 2009-07-01 |
| Terminated | Trial of High Dose Lenalidomide in Patients With MDS and AML With Trilineage Dysplasia Myelodysplastic Syndrome | Phase 2 | 2009-07-01 |
| Completed | Concentration and Activity of Lapatinib in Vestibular Schwannomas Vestibular Schwannoma, NF2, Neurofibromatosis 2 | EARLY_Phase 1 | 2009-06-01 |
| Completed | Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY Lymphoma, Multiple Myeloma, Leukemia | Phase 1 / Phase 2 | 2009-05-01 |
| Completed | Topical Application of Sulforaphane-containing Broccoli Sprout Extracts on Radiation Dermatitis Breast Cancer, Dermatitis | — | 2009-04-15 |
| Active Not Recruiting | Johns Hopkins Breast Cancer Program Longitudinal Repository Breast Cancer, Benign Breast Disease | — | 2009-04-01 |
| Completed | Study to Evaluate the Effect of Sulforaphane in Broccoli Sprout Extract on Breast Tissue Breast Cancer | Phase 2 | 2009-04-01 |
| Completed | Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreat Pancreatic Cancer | Phase 1 | 2009-02-01 |
| Terminated | R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma Non-Hodgkin's Lymphoma | Phase 2 | 2009-01-01 |
| Completed | Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate Prostate Cancer | Phase 2 | 2008-12-22 |
| Completed | Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy MDS, Leukemias, Lymphomas | Phase 2 | 2008-12-01 |
| Completed | Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Ca Breast Cancer | Phase 2 | 2008-12-01 |
| Terminated | Phase II Study of Itraconazole and Pemetrexed in Patients With Previously Treated Non-Squamous NSCLC Recurrent Non Small Cell Lung Cancer | Phase 2 | 2008-11-01 |
| Completed | Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia Cervical Cancer, Precancerous Condition, HPV Disease | Phase 1 | 2008-11-01 |
| Terminated | Phase II Study of Doxorubicin and Avastin® in Sarcoma. Sarcoma, Soft Tissue Sarcoma | Phase 2 | 2008-09-01 |
| Completed | Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Th Pancreatic Cancer | Phase 2 | 2008-07-02 |
| Terminated | Non-Myeloablative Bone Marrow Transplant for Patients With Sickle Cell Anemia and Other Blood Disorders Sickle Cell Disease | Phase 2 | 2008-06-23 |
| Completed | Screening for Early Pancreatic Neoplasia (Cancer of the Pancreas Screening or CAPS4 Study) Early Pancreatic Neoplasia, Familial Pancreatic Neoplasia | — | 2008-06-01 |
| Completed | Magnetic Acupressure in Reducing Pain in Cancer Patients Undergoing Bone Marrow Aspiration and Biopsy Hematopoietic/Lymphoid Cancer, Pain | N/A | 2008-05-07 |
| Active Not Recruiting | Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Brea Breast Cancer | Phase 2 | 2008-05-01 |
| Terminated | Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer Prostate Cancer | Phase 2 | 2008-05-01 |
| Completed | Trial of Partial Breast Irradiation With Various Concurrent Chemotherapy Regimens Breast Cancer | N/A | 2008-04-01 |
| Terminated | Standard Pain Control or Intrathecal Therapy in Controlling Pain in Patients With Locally Advanced, Unresectab Pain, Pancreatic Cancer | N/A | 2008-03-01 |
| Completed | Study of Colon GVAX and Cyclophosphamide in Patients With Metastatic Colorectal Cancer Colorectal Cancer, Metastatic Cancer | Phase 1 | 2008-03-01 |
| Terminated | Testosterone Gel in Preventing Weakness Caused by Steroid Therapy in Men With Glioma Brain and Central Nervous System Tumors, Musculoskeletal Complications | N/A | 2008-01-01 |
| Terminated | Transplantation of Umbilical Cord Blood Following Chemotherapy for Blood Cancers Acute Myeloid Leukemia, Leukemia, Lymphoblastic, Acute, Leukemia, Bilineage, Acute | Phase 1 / Phase 2 | 2007-12-20 |
| Completed | Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma Multiple Myeloma and Plasma Cell Neoplasm | Phase 1 / Phase 2 | 2007-11-01 |
| Completed | Hydroxychloroquine, Radiation, and Temozolomide Treating Patients With Newly Diagnosed Glioblastoma Multiforme Brain and Central Nervous System Tumors | Phase 1 / Phase 2 | 2007-10-29 |
| Terminated | Interferon Alfa and Interleukin-6 in Treating Patients With Recurrent Multiple Myeloma Multiple Myeloma and Plasma Cell Neoplasm | EARLY_Phase 1 | 2007-10-01 |
| Terminated | Studying Fentanyl in Patients With Cancer Brain and Central Nervous System Tumors, Chronic Myeloproliferative Disorders, Leukemia | — | 2007-10-01 |
| Terminated | Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Myelodysplastic Syndrome, Acute Myeloid Leukemia, Myeloproliferative Disorders | Phase 1 | 2007-09-01 |
| Terminated | Vaccine Therapy in Treating Patients With Myelodysplastic Syndromes Myelodysplastic Syndromes | EARLY_Phase 1 | 2007-09-01 |
| Terminated | Freehand Ultrasound Elasticity Imaging in Liver Surgery Liver Tumors | — | 2007-09-01 |
| Completed | Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI. Hepatocellular Carcinoma | N/A | 2007-09-01 |
| Completed | Ultrasound Based Localization of Lumpectomy Bed in Anatomical Coordinate System Resected Breast Cancer, Breast Cancer | — | 2007-08-01 |
| Completed | Identifying Circulating Breast Cancer Cells in Women With Metastatic Breast Cancer Breast Cancer | — | 2007-08-01 |
| Terminated | Infrastructure for Developing Gastrointestinal Cancer Prognostic and Predictive Markers Gastrointestinal Cancer | — | 2007-08-01 |
| Completed | Safety and Efficacy Study of I-131 Tositumomab in Patients With Relapsed/Refractory Hodgkin's Lymphoma Hodgkin's Disease | Phase 1 / Phase 2 | 2007-06-01 |
| Terminated | Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer Cancer | EARLY_Phase 1 | 2007-06-01 |
| Completed | A Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract Head and Neck Squamous Cell Carcinoma | Phase 2 | 2007-05-08 |
| Terminated | Safety Study to Determine the Appropriate Dose of Antibody Against Tumor Cells to Best Target Patients With Pa Pancreatic Cancer | EARLY_Phase 1 | 2007-05-01 |
| Completed | High-Dose Cyclophosphamide for Steroid Refractory GVHD Graft Versus Host Disease | Phase 2 | 2007-05-01 |
| Completed | Cetuximab in Treating Patients With Precancerous Lesions of the Upper Aerodigestive Tract Head and Neck Cancer, Precancerous Condition | Phase 2 | 2007-05-01 |
| Completed | Musculoskeletal Outcomes After Bone Marrow Transplant Survivors of Bone Marrow Transplant, Autologous and Allogeneic | — | 2007-05-01 |
| Completed | Oral HPV Infection in Young Men Head and Neck Cancer, Infection, Precancerous Condition | — | 2007-05-01 |
| Terminated | Vaccine Therapy in Treating Patients Who Have Received First-Line Therapy for Hodgkin's Lymphoma Lymphoma | Phase 1 / Phase 2 | 2007-04-01 |
| Terminated | Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Ac Leukemia, Multiple Myeloma and Plasma Cell Neoplasm | Phase 1 | 2007-04-01 |
| Completed | Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Brain and Central Nervous System Tumors | Phase 1 | 2007-02-01 |
| Completed | Making Decisions About Participating in a Cancer Clinical Trial for Patients With Stage II, Stage III, or Stag Colorectal Cancer, Pancreatic Cancer, Psychosocial Effects of Cancer and Its Treatment | N/A | 2007-01-19 |
| Completed | Lenalidomide and Vaccine Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | 2007-01-01 |
| Completed | DNA in Predicting Response After Systemic Therapy in Women With Metastatic Breast Cancer Breast Cancer | — | 2007-01-01 |
| Terminated | MRX, Radiation, and Chemotherapy for Patients With Resected Squamous Cell Carcinoma of the Head and Neck Squamous Cell Carcinoma, Head and Neck Cancer, Resected Head and Neck Cancer | Phase 1 | 2007-01-01 |
| Completed | Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma Brain and Central Nervous System Tumors | Phase 1 / Phase 2 | 2007-01-01 |
| Completed | Pattern of Cell Death Following Neoadjuvant Therapy for Metastatic Colon Cancer Metastatic Colorectal Cancer | — | 2006-12-01 |
| Withdrawn | Plastic Stents Compared With Metal Stents in Treating Patients With Malignant Dysphagia Caused by Esophageal C Esophageal Cancer, Gastrointestinal Complications | N/A | 2006-12-01 |
| Terminated | Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Thera Brain and Central Nervous System Tumors, Thrombocytopenia | — | 2006-11-11 |
| Completed | Bexarotene and GM-CSF in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases | Phase 2 | 2006-11-01 |
| Completed | Prospective Assessment of Symptoms and Quality of Life in Rectal Cancer Patients Receiving Chemo-Radiotherapy Rectal Cancer | — | 2006-11-01 |
| Completed | Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma Brain and Central Nervous System Tumors | Phase 1 | 2006-10-12 |
| Terminated | Cyclophosphamide Plus T-Cell Transplantation for Patients With Hematologic Malignancies Leukemia, Myelodysplastic Syndromes | Phase 1 | 2006-10-01 |
| Withdrawn | Study of Mitomycin-C in Patients With Advanced or Recurrent Pancreatic Cancer With Mutated BRCA2 Gene Pancreatic Cancer | Phase 2 | 2006-10-01 |
| Terminated | Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Colorectal Cancer | Phase 2 | 2006-10-01 |
| Completed | Adjuvant GVAX Vaccine Therapy in Patients With Pancreatic Cancer Pancreatic Cancer | Phase 2 | 2006-09-11 |
| Completed | Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML o Leukemia | Phase 2 | 2006-09-01 |
| Completed | Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-S Lung Cancer | Phase 2 | 2006-09-01 |
| Completed | Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HE Breast Neoplasms | Phase 2 | 2006-09-01 |
| Completed | Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer Prostate Cancer | Phase 1 / Phase 2 | 2006-08-01 |
| Withdrawn | Cyclophosphamide and Rituximab Followed By Vaccine Therapy in Treating Patients With Chronic Lymphocytic Leuke Leukemia | Phase 2 | 2006-08-01 |
| Completed | Study of 2 Different Doses of Revlimid in Biochemically Relapse Prostate Cancer Prostate Cancer | Phase 1 / Phase 2 | 2006-07-20 |
| Completed | Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma Lymphoma | — | 2006-07-01 |
| Terminated | One Time Injection of Bacteria to Treat Solid Tumors That Have Not Responded to Standard Therapy Tumors | Phase 1 | 2006-07-01 |
| Terminated | Protein Biomarker in Hepatocellular Carcinoma Normal Volunteers, Hepatitis, Liver Cirrhosis | — | 2006-06-20 |
| Completed | Transitoriness in Cancer Patients, Psychosocial Issues in Cancer Care Lung Cancer, Gastrointestinal Cancers | — | 2006-06-01 |
| Completed | Epidermal Growth Factor Receptor Mutations in the Blood of Patients With Advanced Non-Small Cell Lung Cancer Lung Cancer | — | 2006-06-01 |
| Completed | Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Breast Cancer | Phase 2 | 2006-06-01 |
| Completed | Spect Analysis of Cardiac Perfusion Changes After Whole Breast/Chest Wall Radiation Therapy With ABC Breast Neoplasms, Carcinoma, Ductal, Adenocarcinoma | N/A | 2006-06-01 |
| Completed | Study of Robotic Template Guidance for Needle Placement in Transperineal Prostate Brachytherapy Prostate Cancer | N/A | 2006-06-01 |
| Completed | Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on Biomarkers in Women With Stage I, S Breast Cancer | — | 2006-05-01 |
| Completed | Melanoma Biomarker Study Metastatic Melanoma | — | 2006-05-01 |
| Completed | Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma Lymphoma | Phase 2 | 2006-05-01 |
| Terminated | Iodine I 131 in Treating Patients With Thyroid Cancer Head and Neck Cancer | N/A | 2006-04-01 |
| Completed | ChemoRT With Adjuvant Chemo in Pancreatic Cancer (TARCEVA) Pancreatic Cancer | Phase 2 | 2006-03-16 |
| Completed | Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer Breast Cancer | Phase 2 | 2006-03-01 |
| Terminated | Modafinil in Opioid Induced Sedation Cancer, Pain | Phase 3 | 2006-01-01 |
| Completed | Neo-adjuvant Chemotherapy in Locally Advanced Gastric Cancer Stage T3-4NxM0 Gastric Cancer | Phase 2 | 2006-01-01 |
| Completed | Radiation Therapy and Temozolomide Followed by Temozolomide and Poly ICLC in Treating Patients With Newly Diag Glioblastoma Multiforme | Phase 2 | 2006-01-01 |
| Completed | Screening for Lung Cancer in the HIV Patient Lung Cancer in the HIV Patient, HIV Infections, HIV Seropositivity | — | 2006-01-01 |
| Terminated | Identification of a Screening Tool and Treatment of Lymphedema Secondary to the Management of Breast Cancer St Breast Cancer, Lymphedema | N/A | 2006-01-01 |
| Completed | Vaccine Therapy, Cyclophosphamide, and Cetuximab in Treating Patients With Metastatic or Locally Advanced Panc Pancreatic Cancer | Phase 2 | 2005-12-01 |
| Completed | Capecitabine as Second-Line Therapy in Treating Patients With Stage IV Pancreatic Cancer Who Have the Thymidyl Pancreatic Cancer | Phase 2 | 2005-12-01 |
| Completed | Clofarabine and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Leukemia, Chronic Myel Chronic Myeloproliferative Disorders, Leukemia, Myelodysplastic/Myeloproliferative Diseases | Phase 1 | 2005-11-01 |
| Completed | Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer Breast Cancer | Phase 1 | 2005-11-01 |
| Completed | Rituximab and Cyclophosphamide Followed by Vaccine Therapy in Treating Patients With Relapsed Hodgkin Lymphoma Lymphoma | Phase 1 / Phase 2 | 2005-11-01 |
| Terminated | Infrared Thermography in Finding Skin Lesions in Patients With Kaposi's Sarcoma Sarcoma | N/A | 2005-10-03 |
| Terminated | Individualized Drug Treatment for Treating Patients With Pancreatic Cancer Pancreatic Cancer | Phase 2 | 2005-10-01 |
| Terminated | Study of PET Scans and Serotonin in Hot Flashes Treatment Hot Flashes | N/A | 2005-10-01 |
| Terminated | Ex Vivo Expansion of Mafosfamide Purged CD34+ Cells in Patients With Acute Leukemia Leukemia | Phase 1 | 2005-10-01 |
| Terminated | Liposomal Doxorubicin (Lipo-Dox) in Patients With Brain Metastasis From Breast Cancer Breast Cancer | Phase 2 | 2005-09-01 |
| Terminated | Rituximab, Temozolomide, and Methylprednisolone in Treating Patients With Recurrent Primary CNS Non-Hodgkin's Lymphoma | Phase 2 | 2005-09-01 |
| Completed | Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Lung Cancer | Phase 2 | 2005-07-01 |
| Completed | Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small C Lung Cancer | Phase 2 | 2005-07-01 |
| Completed | Erlotinib in Treating Patients With Metastatic and/or Recurrent Head and Neck Cancer Head and Neck Cancer | Phase 2 | 2005-07-01 |
| Completed | Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemi Leukemia, Lymphoma | Phase 2 | 2005-07-01 |
| Terminated | Rituximab and GM-CSF in Treating Patients With Chronic Lymphocytic Leukemia Leukemia | Phase 2 | 2005-07-01 |
| Completed | Collecting and Storing Samples of Blood From Patients With Pancreatic Cancer and Healthy Participants Pancreatic Cancer | — | 2005-05-01 |
| Terminated | Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients Esophageal Cancer | Phase 2 | 2005-04-01 |
| Completed | Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed G Brain and Central Nervous System Tumors, Thromboembolism | — | 2005-04-01 |
| Completed | Tumor DNA and MRI/CT Scan Findings in Patients With Grade III or Grade IV Malignant Glioma High Grade Glioma | N/A | 2005-04-01 |
| Terminated | Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and P Brain and Central Nervous System Tumors | Phase 2 | 2005-02-15 |
| Completed | Study of Image-guided Dosimetry for Interstitial Prostate Brachytherapy Locally Confined Adenocarcinoma of the Prostate | Phase 1 | 2005-02-01 |
| Completed | Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's Lymphoma Leukemia, Lymphoma | Phase 2 | 2005-01-01 |
| Completed | Sirolimus in Treating Patients With Advanced Pancreatic Cancer Pancreatic Cancer | Phase 2 | 2005-01-01 |
| Completed | Broccoli Sprout Extract in Preventing Lung Cancer in Smokers Lung Cancer | N/A | 2005-01-01 |
| Completed | Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer Prostate Cancer | Phase 1 | 2004-12-01 |
| Completed | Sirolimus in Treating Patients With Metastatic or Unresectable Solid Tumors Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2004-12-01 |
| Completed | Rituximab and Cyclophosphamide in Treating Patients With High Risk, Refractory, or Relapsed Multiple Myeloma Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | 2004-12-01 |
| Completed | Erlotinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III, Stage IV, or Recurrent Non-Small C Lung Cancer | Phase 2 | 2004-11-01 |
| Completed | Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas Brain and Central Nervous System Tumors | Phase 1 | 2004-11-01 |
| Terminated | Irinotecan in Treating Patients With Metastatic or Inoperable Thyroid Cancer Head and Neck Cancer | Phase 2 | 2004-11-01 |
| Completed | Samarium Sm 153 and Stem Cell Transplant Followed By Radiation Therapy Patients With Osteosarcoma Sarcoma | Phase 2 | 2004-10-01 |
| Completed | Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia Leukemia | Phase 2 | 2004-10-01 |